U.S. Paper and Forestry Products Stock News

NYSE:KRC
NYSE:KRCOffice REITs

Kilroy Realty (KRC) Faces A Fresh Valuation Test Following Earnings And Acquisition Plans

Why Kilroy Realty stock is back in focus Kilroy Realty (KRC) is drawing fresh attention after reporting second quarter 2026 results that showed lower revenue and a sharp drop in net income, while management outlined plans to pursue new acquisition opportunities. See our latest analysis for Kilroy Realty. Kilroy Realty’s latest earnings, acquisition plans, completed buyback program and new shelf registration come against a backdrop of mixed momentum, with the share price delivering a 9.33% 90...
NYSE:CFG
NYSE:CFGBanks

Large Cap Dividend Stocks For Income Investors As Rate Cut Hopes Build

With Asian stocks climbing and the odds of a US rate hike in September easing, income investors are watching a rare mix of relief and uncertainty. Lower rate expectations can change how dividend stocks trade, especially with CPI data and rising oil prices still in play. This article walks through three large cap dividend stocks from our screener that appear well placed, highlighting where the current backdrop may help or hinder your income plan. The three stocks below are a useful starting...
NYSE:AIG
NYSE:AIGInsurance

American International Group (AIG) Could Be 11% Undervalued As Q2 Earnings Slip

American International Group (AIG) has drawn fresh attention after reporting second quarter 2026 results that showed slightly lower revenue and net income. Earnings per share also softened compared with the same period last year. See our latest analysis for American International Group. At a share price of $78.78, American International Group has seen its short term share price performance soften, with the 1 day and year to date share price returns both declining. At the same time, the 1 year...
NYSE:ESAB
NYSE:ESABMachinery

Will Record Sales, Eddyfi Deal and Raised 2026 Outlook Change ESAB's (ESAB) Margin Narrative?

ESAB Corporation recently reported its second-quarter 2026 results, with sales rising to US$807.63 million from US$715.59 million a year earlier, while net income fell to US$32.35 million from US$66.88 million. Alongside record sales and an earnings miss, ESAB closed the Eddyfi acquisition ahead of schedule and raised its 2026 outlook, tying short-term margin pressure to what management describes as stronger long-term demand and expanded technology capabilities. We’ll now examine how ESAB’s...
NYSE:CYD
NYSE:CYDMachinery

Did Stronger H1 Earnings and Genset IPO Plans Just Shift China Yuchai International's (CYD) Investment Narrative?

China Yuchai International Limited recently reported half-year 2026 results showing sales of CNY 14,666.43 million and net income of CNY 560.6 million, both higher than a year earlier, with basic earnings per share from continuing operations rising to CNY 14.94. Investors are also focusing on the company’s push into high-horsepower and alternative-fuel engines, including marine, power generation, and AI data-center applications, alongside a planned Hong Kong IPO for its genset power...
NYSE:TTI
NYSE:TTIEnergy Services

TETRA Technologies (TTI) Could Be 32% Below Fair Value After Arkansas Bromine Approval

Why the latest earnings matter for TETRA Technologies stock TETRA Technologies (TTI) has become a focus for investors after its second quarter earnings on 3 August 2026, which paired revenue and EBITDA growth with a final go ahead for the Arkansas bromine project. See our latest analysis for TETRA Technologies. Over the past year TETRA Technologies has delivered a very strong 1 year total shareholder return of 117.09%. However, the share price is down 16.40% over 3 months and 9.95% over 30...
NYSE:KMI
NYSE:KMIOil and Gas

Is Kinder Morgan (KMI) Undervalued After Its New Bond Offerings?

Why Kinder Morgan stock is back in focus after new bond offerings Kinder Morgan (KMI) recently completed several fixed income offerings, including senior unsecured fixed rate notes with attached guarantees. These new bonds give investors fresh information about the company’s funding mix and balance sheet decisions. The transactions include US$595.782 million of 6.150% notes due August 1, 2056 and US$1.149138 billion of 5.550% notes due August 1, 2036. Both sets of notes are senior, unsecured,...
NYSE:IT
NYSE:ITIT

Gartner (IT) Is Back In Focus After Fresh Guidance, But Does Valuation Still Look Rich?

Why Gartner Stock Is Back in Focus After Fresh Guidance Gartner (IT) is back on investor watch after issuing updated full year 2026 guidance alongside second quarter results. The company now expects revenue of at least $6.375b on an FX neutral growth rate of 1%. The company also reported June quarter earnings and progress on a long running share repurchase program, giving investors fresh numbers to assess Gartner stock after recent price moves. See our latest analysis for Gartner. Gartner...
NYSE:RXO
NYSE:RXOTransportation

RXO (RXO) Is Up 7.2% After Strong Brokerage Growth Narrows Losses - Has The Bull Case Changed?

In the past quarter, RXO, Inc. reported second-quarter 2026 results showing sales of US$1,774 million versus US$1,419 million a year earlier, with a net loss of US$9 million and basic and diluted loss per share from continuing operations unchanged at US$0.05. Despite a wider six-month net loss of US$45 million versus US$40 million a year earlier, RXO’s brokerage revenue growth and better-than-expected performance in brokerage and last-mile operations pointed to improving operating momentum...
NasdaqGS:SIGI
NasdaqGS:SIGIInsurance

Selective Insurance Group (SIGI) Leans On Efficiency Story, Does It Look Fairly Valued?

Why Selective Insurance Group Is On Investor Radar Today Selective Insurance Group (SIGI) is drawing investor attention after recent trading put its shares around $96.23, with performance figures available for the past week, month, past 3 months, year to date, and 1 year. See our latest analysis for Selective Insurance Group. Recent trading puts Selective Insurance Group’s share price at $96.23, with a 12.04% 90 day share price return and a 26.54% 1 year total shareholder return. This may...
NYSE:MTX
NYSE:MTXChemicals

How Investors Are Reacting To Minerals Technologies (MTX) Margin-Recovery Guidance After a Surprise Quarterly Loss

Minerals Technologies recently reported second-quarter 2026 results, with sales rising to US$548.4 million but swinging to a net loss of US$183.6 million, and followed this with full-year 2026 guidance calling for around US$75 million in quarterly operating income and earnings per share between US$1.55 and US$1.60. Management acknowledged near-term pressure but emphasized a planned recovery in operating margins above prior-year levels in the fourth quarter, underpinned by seasonality and...
NYSE:ELF
NYSE:ELFPersonal Products

e.l.f. Beauty (ELF) Lifts Guidance After Strong Earnings, Where Does Fair Value Sit?

What the latest guidance and earnings mean for e.l.f. Beauty stock e.l.f. Beauty (ELF) raised its fiscal 2027 net sales guidance to a range of US$1.94b to US$1.97b, alongside first quarter 2026 results that showed higher sales, net income and earnings per share year over year. The updated outlook now implies an 18% to 20% year over year net sales change for 2027, compared with a previously guided 12% to 14% range. This gives investors a clearer view of management’s current expectations for...
NasdaqGS:MSEX
NasdaqGS:MSEXWater Utilities

Middlesex Water (MSEX), Why Is Its Latest Update Drawing Attention?

Middlesex Water (MSEX) is in focus after reporting second quarter 2026 results, with sales of US$56.36 million and net income of US$14.77 million, both above the figures reported a year earlier. See our latest analysis for Middlesex Water. Middlesex Water’s recent earnings release has arrived alongside a firm share price recovery, with a 5.84% 1 month share price return, a 12.11% 3 month share price return and a 15.81% year to date share price return. The 1 year total shareholder return of...
NYSE:FLR
NYSE:FLRConstruction

Fluor (FLR) Is Up 13.6% After Raising 2026 Guidance On Backlog Surge And New Nuclear Hire – Has The Bull Case Changed?

Fluor Corporation reported past second-quarter 2026 results with sales of US$4,329 million and net income of US$114 million, while raising full-year adjusted EBITDA and operating cash flow guidance on the back of over US$6 billion in new awards that lifted backlog to about US$26.90 billion. Alongside these results, Fluor added retired U.S. Navy Admiral James F. (Frank) Caldwell Jr. to its board and key committees, underscoring the company’s emphasis on nuclear expertise and governance as it...
NasdaqGS:GRAL
NasdaqGS:GRALBiotechs

Did FDA’s Galleri PMA Panel Date Just Shift GRAIL's (GRAL) Multi‑Cancer Screening Narrative?

GRAIL announced that the FDA’s Molecular and Clinical Genetics Panel will meet on September 23, 2026, to review its Premarket Approval application for the Galleri multi-cancer early detection blood test, which uses methylation patterns and artificial intelligence to detect cancer signals and predict their origin alongside existing screening methods. The PMA filing leans on extensive data from the PATHFINDER 2 study of 25,490 U.S. participants and over 70,000 participants from the NHS-Galleri...
NasdaqGS:BJRI
NasdaqGS:BJRIHospitality

Did Rising Sales but Weaker Margins Just Shift BJ's Restaurants' (BJRI) Turnaround Investment Narrative?

BJ's Restaurants, Inc. recently reported past second-quarter 2026 results showing sales rising to US$388.89 million while net income fell to US$18.78 million, with diluted EPS from continuing operations slipping to US$0.86. Despite higher revenue and ongoing share repurchases under its long-running buyback program, the latest results underscore pressure on profitability as costs outpaced sales growth. Next, we’ll examine how rising sales but softer margins in the latest quarter may influence...
NasdaqGS:IQ
NasdaqGS:IQEntertainment

iQIYI’s New Undercurrent Theater Short-Form Suspense Slate Could Be A Game Changer For iQIYI (IQ)

In early August 2026, iQIYI launched Undercurrent Theater, a horizontal short-form suspense drama brand featuring 10–25 minute, cinematic-quality episodes, now streaming on both its domestic and international platforms. By transplanting its Suspense Theater production discipline into a short-form format, iQIYI is aiming to turn premium micro-length suspense series into a distinct content brand that can stand apart from mainstream short-video platforms. We’ll now examine how building a...
NasdaqGS:HSIC
NasdaqGS:HSICHealthcare

Henry Schein (HSIC) Lifts Outlook As Earnings Improve While Valuation Looks Full

Guidance Change and Earnings Put Henry Schein in Focus Henry Schein (HSIC) raised its 2026 sales growth outlook to a range of 4.5% to 5.5%, alongside second quarter results showing higher sales, net income, and earnings per share compared with the prior year period. See our latest analysis for Henry Schein. Henry Schein’s recent guidance increase and earnings report come alongside a 27.08% 3 month share price return and a 33.33% 1 year total shareholder return. This signals building momentum...
NasdaqGS:CEG
NasdaqGS:CEGElectric Utilities

Constellation Energy (CEG) Lifted Guidance And Secured New Deals, Is It Still Undervalued?

Constellation Energy (CEG) has become a focus for investors after it raised full year adjusted operating earnings guidance and outlined new long term power purchase agreements, alongside regulatory progress on the Crane Clean Energy Center restart. See our latest analysis for Constellation Energy. Constellation Energy’s latest guidance increase and long term contracts come after a mixed year for investors, with the share price down 26.31% year to date but supported by a three year total...
NasdaqGS:AVT
NasdaqGS:AVTElectronic

Can Avnet (AVT) Still Look Undervalued As Earnings, Guidance And Buybacks Land?

How Avnet’s latest earnings, guidance and buyback frame the stock Avnet (AVT) just released fourth quarter and full year results, issued new first quarter guidance, and confirmed progress on its multi year share repurchase plan, giving investors several fresh data points to consider. See our latest analysis for Avnet. The latest earnings, first quarter guidance and ongoing buyback come after a strong share price run, with a year to date share price return of 95.64% and a 5 year total...
NYSE:CNMD
NYSE:CNMDMedical Equipment

Is CONMED’s (CNMD) Earnings Beat And Higher Sales Outlook Reframing Its Core Investment Story?

In July 2026, CONMED Corporation reported past second-quarter 2026 results showing sales of US$343.49 million and net income of US$23.07 million, alongside higher basic and diluted earnings per share from continuing operations compared with a year earlier. For the first half of 2026, CONMED grew net income to US$36.90 million despite slightly lower sales, and marginally raised its full-year GAAP net sales guidance range to US$1.36 billion–US$1.37 billion. Now we’ll examine how this earnings...
NasdaqGM:NRIX
NasdaqGM:NRIXBiotechs

Why Nurix Therapeutics (NRIX) Is Back In The Spotlight

Nurix Therapeutics (NRIX) is in focus after enrolling the first patient in its global Phase 3 DAYBreak CLL-306 trial of BTK degrader bexobrutideg with Roche, alongside a separate $10 million milestone payment from Sanofi. See our latest analysis for Nurix Therapeutics. The latest clinical and partnership milestones appear to be feeding into building momentum in Nurix Therapeutics' stock, with a 90 day share price return of 56.82% and a 1 year total shareholder return of 159.45%. This...
NYSE:AVNT
NYSE:AVNTChemicals

Is Avient (AVNT) Still Below Fair Value After Strong Earnings And Raised Guidance?

Why Avient’s latest earnings matter for investors Avient (AVNT) reported second quarter 2026 earnings on August 6, with higher sales, earnings and a record adjusted EBITDA margin, alongside raised full year guidance and continued debt repayment. This combination of operational and cash flow updates gives you fresh information on how the company is performing and what management currently expects for the rest of 2026. See our latest analysis for Avient. Avient’s latest earnings have arrived...